HSBC plans trigger jump notes tied to iShares Nasdaq Biotechnology

By Susanna Moon

Chicago, Nov. 15 – HSBC USA Inc. plans to price 0% trigger jump securities due Dec. 4, 2019 linked to the iShares Nasdaq Biotechnology exchange-traded fund, according to an FWP filing with the Securities and Exchange Commission.

If the fund finishes at or above the initial price, the payout at maturity will be par of $10 plus the upside return of at least 34.75%.

If the fund falls but finishes at or above the 80% trigger level, the payout will be par.

If the fund falls by more than 20%, investors will be fully exposed to any losses.

HSBC Securities (USA) Inc. is the agent.

The notes will price on Nov. 30 and settle on Dec. 5.

The Cusip number is 40435C401.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.